Water Vapor Ablation for Prostate Cancer: Long-Term Registry
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The purpose of the registry is to evaluate real-world safety, efficacy, and patient reported outcomes among participants receiving Vanquish Water Vapor Ablation System therapy (Vanquish Therapy). This includes longitudinal assessment of patients who have received or will receive the therapy one or multiple times as part of routine clinical care and encompasses those who completed a company-sponsored Vanquish therapy study (as applicable).
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Pacjent zalecany do terapii Vanquish przez lekarza lub uczestnik wcześniejszego badania finansowanego przez producenta
- •Chęć uczestnictwa i możliwość podpisania świadomej zgody
✗ Disqualifies
- •Przeciwwskazania do terapii Vanquish zgodnie z instrukcją użytkownika
- •Wcześniejszy udział w badaniu VAPOR 2 bez planów na kolejne leczenie
Simplified criteria — AI translation
Trial details
- Last updated (source)
- August 18, 2026
- Sex
- Male only
Therapies / drugs in trial
Locations (4)
WK Advanced Urology Specialists
Bossier City, United States
Minnesota Urology
Woodbury, United States
The Urology Place, Inc.
San Antonio, United States
Urology of Virginia
Virginia Beach, United States
Trial contact
Sydney Cartie
Garrett Grenier
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 8/19/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.